SEC Form 4 · accession 0001354488-16-006404
PERNIX THERAPEUTICS HOLDINGS, INC. · PTX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Sanjay S Patel
Officer — Chief Financial Officer
Period of report
Feb 25, 2016
Accepted (ET)
Feb 29, 2016 · 4:48 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001024126
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Option (right to buy)F1 | $2.14 | Feb 25, 2016 | A | 350,000 | A | — | Feb 25, 2026 | Common Stock | 350,000 | 350,000 | D |
Explanation of responses
- F1The stock options vest in annual 87,500 share installments with the first installment vesting on the first anniversary date of grant and the final installment vesting on the fourth anniversary thereof.